Nutex Health, Inc.(NUTX)Earnings, Financials & Key Ratios

NUTX•NASDAQ

$130.59

$778M mkt cap·12.5× P/E·Price updated May 6, 2026

SectorHealthcare IndustryHealthcare IT Sub-IndustryCare Delivery Networks and Value-Based Care

AboutNutex Health, Inc. operates as a technology-enabled healthcare services company. It operates through two divisions: Hospital division and Population Health Management division. The Hospital division implements and operates health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments. This division owns and operates 21 facilities in 8 states. The Population Health Management division owns and operates provider networks, such as independent physician associations. Its management services organizations provide management, administrative, and other support services to its affiliated hospitals and physician groups. This division's cloud-based proprietary technology platform aggregates data across multiple information systems, settings, and sources to create a holistic view of each patient and provider, as well as allows to deliver care. The company is based in Houston, Texas.Show more

Revenue$875M+82.4%
EBITDA$296M+98.0%
Net Income$71M+35.7%
EPS (Diluted)10.48+7.9%
Gross Margin50.76%+24.1%
EBITDA Margin33.84%+8.6%
Operating Margin31.49%+15.7%
Net Margin8.09%-25.6%
ROE22.64%-39.0%
ROIC38%+61.3%
Debt/Equity0.83-50.8%
Interest Coverage12.01+84.6%

Technical→

NUTX Key Insights

Nutex Health, Inc. (NUTX) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

✓Strong Piotroski F-Score: 7/9
✓FCF machine: 28.1% free cash flow margin
✓High quality earnings: Operating CF exceeds net income
✓Strong 5Y sales CAGR of 26.1%

✗Weaknesses

✗Weak 3Y average ROE of 4.6%
✗Shares diluted 32.5% in last year
✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

NUTX Price & Volume

Nutex Health, Inc. (NUTX) stock price & volume — 10-year historical chart

Loading chart...

NUTX Growth Metrics

Nutex Health, Inc. (NUTX) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-

5 Years26.14%

3 Years58.62%

TTM40.95%

Profit CAGR

10 Years96.19%

5 Years-7.75%

3 Years-

TTM43.47%

EPS CAGR

10 Years74.25%

5 Years-15.75%

3 Years-

TTM8.36%

Return on Capital

10 Years-32.65%

5 Years1.57%

3 Years21.65%

Last Year43.23%

NUTX Recent Earnings

Nutex Health, Inc. (NUTX) EPS & revenue vs analyst estimates — last 4 quarters

Full history →

●Beat EPS 6/12 qtrs (60%)●Beat Revenue 6/12 qtrs (50%)

Q2 2026Latest

Apr 30, 2026

EPS

$6.52

Est $3.99

+63.4%

Revenue

$216M

Est $228M

-5.0%

Q2 2026

Mar 5, 2026

EPS

$1.61

Est $5.56

-71.0%

Revenue

$152M

Est $259M

-41.4%

Q4 2025

Nov 19, 2025

EPS

$7.76

Est $1.81

+328.7%

Revenue

$268M

Est $214M

+25.3%

Q4 2025

Oct 8, 2025

EPS

$3.02

Est $5.43

+44.3%

Revenue

$244M

Est $222M

+9.9%

Quarter	Date	EPS (Act vs Est)	Revenue (Act vs Est)
Q2 2026Latest	Apr 30, 2026	$6.52vs $3.99+63.4%	$216Mvs $228M-5.0%
Q2 2026	Mar 5, 2026	$1.61vs $5.56-71.0%	$152Mvs $259M-41.4%
Q4 2025	Nov 19, 2025	$7.76vs $1.81+328.7%	$268Mvs $214M+25.3%
Q4 2025	Oct 8, 2025	$3.02vs $5.43+44.3%	$244Mvs $222M+9.9%

Based on last 12 quarters of dataView full earnings history →

Company	Market Cap	Stock Price	P/E Ratio (TTM)	Revenue Growth 1Y	Net Margin	Return on Equity (ROE)	Debt / Equity
ADUSAddus HomeCare CorporationDirect Competitor	1.8B	96.64	18.55	23.21%	6.89%	9.34%	0.19
AMSFAMERISAFE, Inc.Direct Competitor	556.33M	29.60	11.98	2.63%	14.27%	9.68%	0.00
UHSUniversal Health Services, Inc.Product Competitor	10.55B	168.49	7.29	9.71%	8.56%	20.65%	0.74
THCTenet Healthcare CorporationProduct Competitor	17.04B	194.51	12.56	3.12%	7.94%	19.56%	1.47
CYHCommunity Health Systems, Inc.Product Competitor	404.47M	2.87	0.76	-1.18%	-0.41%
HCAHCA Healthcare, Inc.Product Competitor	96.01B	429.45	15.13	7.08%	8.97%
SGRYSurgery Partners, Inc.Product Competitor	1.89B	14.59	-23.92	6.24%	-2.28%	-2.39%	1.14
USPHU.S. Physical Therapy, Inc.Product Competitor	1.12B	73.61	51.84	16.33%	1.52%	1.36%	0.55

Compare NUTX vs Peers

Nutex Health, Inc. (NUTX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs ADUS

Most directly comparable listed peer for NUTX.

Scale Benchmark

vs HCA

Larger-name benchmark to compare NUTX against a more recognizable public peer.

Peer Set

Compare Top 5

vs ADUS, AMSF, UHS, THC

NUTX Income Statement

Nutex Health, Inc. (NUTX) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Sales/Revenue	53.65K	91.37K	97.06M	274.03M	331.53M	219.29M	247.65M	479.95M	875.26M	879.95M
Revenue Growth %	-	70.32%	106120.79%	182.34%	20.98%	-33.85%	12.93%	93.8%	82.36%	40.95%
Cost of Goods Sold	564.37K	62.3K	0	116.42M	152.25M	203.87M	212.87M	283.69M	430.98M	462.28M
COGS % of Revenue	1052%	68.18%	-	42.49%	45.92%	92.97%	85.96%	59.11%	49.24%	-
Gross Profit	-510.72K▲ 0%	29.07K▲ 105.7%	97.06M▲ 333716.4%	157.61M▲ 62.4%	179.28M▲ 13.8%	15.42M▼ 91.4%	34.77M▲ 125.5%	196.26M▲ 464.4%	444.28M▲ 126.4%	417.67M▲ 0%
Gross Margin %	-952%	31.82%	100%	57.51%	54.08%	7.03%	14.04%	40.89%	50.76%	47.47%
Gross Profit Growth %	-107874.63%	105.69%	333716.41%	62.39%	13.75%	-91.4%	125.49%	464.39%	126.37%	-
Operating Expenses	5.69M	1.8M	62.35M	4.43M	9.02M	422.02M	66.55M	65.64M	168.66M	145.36M
OpEx % of Revenue	10598.18%	1967.03%	64.24%	1.62%	2.72%	192.44%	26.87%	13.68%	19.27%	-
Selling, General & Admin	1.81M	1.16M	59.87M	4.43M	5.46M	20M	36.07M	58.56M	168.66M	56M
SG&A % of Revenue	3380.66%	1273.64%	61.68%	1.62%	1.65%	9.12%	14.56%	12.2%	19.27%	-
Research & Development	25.64K	545.22K	0	0	285.88K	0	0	0	0	0
R&D % of Revenue	47.8%	596.7%	-	-	0.09%	-	-	-	-	-
Other Operating Expenses	3.87M	633.57K	2.48M	0	3.27M	402.02M	30.48M	7.08M	0	1000K
Operating Income	-5.69M▲ 0%	-1.83M▲ 67.8%	34.71M▲ 1996.2%	153.17M▲ 341.3%	170.26M▲ 11.2%	-406.6M▼ 338.8%	-31.77M▲ 92.2%	130.62M▲ 511.1%	275.63M▲ 111.0%	276.23M▲ 0%
Operating Margin %	-10611.81%	-2003.39%	35.76%	55.9%	51.36%	-185.41%	-12.83%	27.22%	31.49%	31.39%
Operating Income Growth %	-1169.04%	67.84%	1996.18%	341.29%	11.16%	-338.8%	92.19%	511.1%	111.01%	-
EBITDA	-5.16M	-1.83M	37.19M	159.07M	178.02M	-393.47M	-14.18M	149.59M	296.15M	297.16M
EBITDA Margin %	-9614.51%	-2002.82%	38.32%	58.05%	53.7%	-179.42%	-5.73%	31.17%	33.84%	33.77%
EBITDA Growth %	-1050.99%	64.52%	2132.1%	327.75%	11.91%	-321.02%	96.4%	1154.79%	97.97%	34.3%
D&A (Non-Cash Add-back)	535.02K	522	2.48M	5.9M	7.76M	13.13M	17.59M	18.97M	20.53M	20.93M
EBIT	-5.64M	-840.33K	35.62M	152.17M	175.69M	-407.16M	-32.17M	129.68M	267.01M	189.72M
Net Interest Income	0	0	-3.53M	-6.43M	-6.2M	-12.49M	-16.32M	-19.93M	-22.23M	-16.11M
Interest Income	0	0	0	0	0	0	0	0	0	0
Interest Expense	-367.35K	-642.07K	3.53M	6.43M	6.2M	12.49M	16.32M	19.93M	22.23M	20.79M
Other Income/Expense	-314.55K	-983.68K	-2.62M	-7.43M	-773.88K	-13.05M	-16.72M	-20.87M	-30.84M	-26.1M
Pretax Income	582.06K▲ 0%	-2.81M▼ 583.5%	32.09M▲ 1240.2%	145.74M▲ 354.2%	169.49M▲ 16.3%	-419.65M▼ 347.6%	-48.49M▲ 88.4%	109.75M▲ 326.3%	244.78M▲ 123.0%	250.13M▲ 0%
Pretax Margin %	1084.99%	-3079.95%	33.06%	53.18%	51.12%	-191.36%	-19.58%	22.87%	27.97%	28.42%
Income Tax	-535.02K	-161.14K	0	181.34K	965.73K	13.09M	-5.07M	14.48M	64.42M	57.81M
Effective Tax Rate %	-91.92%	5.73%	0%	0.12%	0.57%	-3.12%	10.45%	13.19%	26.32%	23.11%
Net Income	582.06K▲ 0%	-2.81M▼ 583.5%	20.92M▲ 843.5%	105.97M▲ 406.5%	132.59M▲ 25.1%	-424.78M▼ 420.4%	-45.79M▲ 89.2%	52.18M▲ 214.0%	70.79M▲ 35.7%	96.38M▲ 0%
Net Margin %	1084.99%	-3079.95%	21.56%	38.67%	39.99%	-193.7%	-18.49%	10.87%	8.09%	10.95%
Net Income Growth %	107.83%	-583.5%	843.47%	406.47%	25.12%	-420.36%	89.22%	213.96%	35.67%	43.47%
Net Income (Continuing)	-6.01M	-950.13K	32.09M	145.56M	168.53M	-432.74M	-43.42M	95.27M	180.36M	176.36M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	22.53M	61.56M	76.93M	24.46M	17.65M	55.55M	93.99M	95.76M
EPS (Diluted)	0.14▲ 0%	-0.39▼ 378.6%	3.98▲ 1120.5%	24.69▲ 520.4%	33.55▲ 35.9%	-100.36▼ 399.1%	-10.39▲ 89.6%	9.71▲ 193.5%	10.48▲ 7.9%	13.43▲ 0%
EPS Growth %	103.89%	-378.57%	1120.51%	520.35%	35.88%	-399.14%	89.65%	193.46%	7.93%	8.36%
EPS (Basic)	0.14	-0.39	3.98	24.69	33.55	-100.50	-10.39	10.23	11.13	-
Diluted Shares Outstanding	4.18M	7.18M	4.14M	4.29M	3.95M	4.23M	4.41M	5.1M	6.76M	7.18M
Basic Shares Outstanding	4.18M	7.18M	4.14M	4.29M	4.02M	4.23M	4.41M	5.1M	6.36M	6.7M
Dividend Payout Ratio	-	-	90.34%	55.72%	108.86%	-	-	12.34%	-	-

NUTX Balance Sheet

Nutex Health, Inc. (NUTX) balance sheet — assets, liabilities & shareholders' equity

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Total Current Assets	55.08K	305.42K	45.74M	135.51M	154.02M	97.97M	90.85M	292.48M	538.81M	579.65M
Cash & Short-Term Investments	9.45K	119.27K	8M	25.51M	36.12M	34.26M	22M	43.58M	185.57M	207.35M
Cash Only	9.45K	119.27K	8M	25.51M	36.12M	34.26M	22M	43.58M	185.57M	207.35M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	6.25K	186.15K	36.14M	108.14M	114.76M	58.32M	62.78M	236.05M	325.42M	339.56M
Days Sales Outstanding	42.55	743.6	135.91	144.04	126.34	97.06	92.52	179.52	135.71	145.94
Inventory	0	27.07K	899.91K	1.73M	2.81M	3.53M	3.39M	2.85M	2.87M	4.68M
Days Inventory Outstanding	-	158.62	-	5.41	6.75	6.33	5.81	3.67	2.43	2.56
Other Current Assets	39.38K	-27.07K	0	0	323.28K	1.87M	0	10M	24.95M	28.06M
Total Non-Current Assets	3.27M	144.01K	133.48M	173.05M	240.63M	333.78M	307.4M	362.84M	379.71M	377.67M
Property, Plant & Equipment	3.85K	7.61K	131.28M	170.81M	238.36M	295.15M	269.39M	324.69M	343.9M	342.18M
Fixed Asset Turnover	13.95x	12.00x	0.74x	1.60x	1.39x	0.74x	0.92x	1.48x	2.55x	2.61x
Goodwill	0	0	3.47M	1.14M	1.14M	17.01M	17.07M	13.92M	13.92M	13.92M
Intangible Assets	3.27M	2.57M	1.54M	0	682.65K	21.19M	20.51M	15.53M	21.23M	20.91M
Long-Term Investments	0	116.96K	100K	0	0	0	0	0	0	0
Other Non-Current Assets	1.95K	19.43K	-2.81M	1.1M	456.08K	423.43K	431.13K	711.35K	662K	2.12M
Total Assets	3.33M▲ 0%	449.43K▼ 86.5%	179.22M▲ 39778.4%	308.55M▲ 72.2%	394.65M▲ 27.9%	431.75M▲ 9.4%	398.25M▼ 7.8%	655.32M▲ 64.6%	918.52M▲ 40.2%	957.32M▲ 0%
Asset Turnover	0.02x	0.20x	0.54x	0.89x	0.84x	0.51x	0.62x	0.73x	0.95x	0.96x
Asset Growth %	551.63%	-86.5%	39778.36%	72.16%	27.9%	9.4%	-7.76%	64.55%	40.16%	284.88%
Total Current Liabilities	959.78K	1.04M	72.13M	31.45M	37.69M	54.86M	58.31M	140.87M	157.91M	184.44M
Accounts Payable	348.35K	567.01K	1.75M	8.63M	17.65M	23.93M	25.28M	13.96M	48.97M	46.45M
Days Payables Outstanding	225.3	3.32K	-	27.06	42.32	42.84	43.35	17.96	41.47	34.55
Short-Term Debt	386.19K	477.06K	13.35M	18.65M	10.23M	15.17M	14.18M	17.95M	14.08M	26.27M
Deferred Revenue (Current)	9.1K	9.19K	165.56K	38.65K	173.92K	0	0	0	0	0
Other Current Liabilities	216.14K	332.19K	3.37M	-38.65K	3.6M	5.61M	0	0	8.26M	111.72M
Current Ratio	0.06x	0.29x	0.63x	4.31x	4.09x	1.79x	1.56x	2.08x	3.41x	3.41x
Quick Ratio	0.06x	0.27x	0.62x	4.25x	4.01x	1.72x	1.50x	2.06x	3.39x	3.39x
Cash Conversion Cycle	-	-2.42K	-	122.39	90.77	60.55	54.99	165.22	96.66	113.95
Total Non-Current Liabilities	0	902.72K	56.26M	129.73M	165.38M	256.56M	260.83M	312.56M	337.18M	330.83M
Long-Term Debt	0	902.72K	40.88M	81.9M	78.82M	23.05M	26.31M	22.47M	29.17M	298.41M
Capital Lease Obligations	0	0	15.38M	47.83M	86.56M	223.06M	229.37M	290.1M	298.91M	888.23M
Deferred Tax Liabilities	0	0	0	0	1.75M	10.45M	5.15M	0	9.09M	32.2M
Other Non-Current Liabilities	0	0	0	0	-1.75M	0	0	0	0	-6.16M
Total Liabilities	959.78K	1.95M	128.39M	161.19M	203.07M	311.42M	319.14M	453.43M	495.09M	515.26M
Total Debt	386.19K	1.38M	119.94M	150.12M	178.55M	267.2M	275.76M	340.3M	351.39M	324.68M
Net Debt	376.74K	1.26M	111.94M	124.61M	142.43M	232.95M	253.75M	296.72M	165.82M	117.33M
Debt / Equity	0.16x	-	2.36x	1.02x	0.93x	2.22x	3.49x	1.69x	0.83x	0.83x
Debt / EBITDA	-	-	3.23x	0.94x	1.00x	-	-	2.27x	1.19x	1.09x
Net Debt / EBITDA	-	-	3.01x	0.78x	0.80x	-	-	1.98x	0.56x	0.56x
Interest Coverage	-15.35x	-1.31x	10.09x	23.66x	28.35x	-32.60x	-1.97x	6.51x	12.01x	9.13x
Total Equity	2.37M▲ 0%	-1.5M▼ 163.2%	50.84M▲ 3495.0%	147.37M▲ 189.9%	191.58M▲ 30.0%	120.33M▼ 37.2%	79.11M▼ 34.3%	201.89M▲ 155.2%	423.44M▲ 109.7%	537.81M▲ 0%
Equity Growth %	140.36%	-163.21%	3495.03%	189.89%	30%	-37.19%	-34.26%	155.22%	109.73%	965.17%
Book Value per Share	0.57	-0.21	12.28	34.34	48.48	28.43	17.94	39.59	62.67	74.93
Total Shareholders' Equity	2.37M	-1.5M	28.31M	85.81M	114.65M	95.86M	61.45M	146.34M	329.45M	442.05M
Common Stock	126.2K	1.77K	4.65K	5.28K	592.79K	650.22K	676.68K	5.51K	7K	7K
Retained Earnings	-9.65M	-5.45M	-12.57M	-18.22M	102.32M	-363.29M	-409.07M	-356.89M	-286.19M	-239.38M
Treasury Stock	-1M	0	0	0	0	0	0	0	0	0
Accumulated OCI	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	22.53M	61.56M	76.93M	24.46M	17.65M	55.55M	93.99M	95.76M

NUTX Cash Flow Statement

Nutex Health, Inc. (NUTX) cash flow — operating, investing & free cash flow history

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Cash from Operations	-714.62K	-480.05K	12.12M	86.67M	173.43M	50.61M	1.26M	23.15M	248.13M	248.13M
Operating CF Margin %	-1332.08%	-525.37%	12.49%	31.63%	52.31%	23.08%	0.51%	4.82%	28.35%	-
Operating CF Growth %	-160.6%	32.82%	2625.71%	614.84%	100.1%	-70.82%	-97.52%	1742.79%	971.64%	133081.19%
Net Income	-6.01M	-950.13K	32.09M	145.56M	168.53M	-432.74M	-43.42M	95.27M	180.36M	96.38M
Depreciation & Amortization	535.02K	522	2.48M	5.96M	7.66M	13.13M	17.59M	18.97M	20.53M	26.49M
Stock-Based Compensation	924.33K	208.03K	0	0	0	189.58K	2.84M	16.63M	117M	121.54M
Deferred Taxes	-115.22K	-123.43K	0	0	0	5M	-5.71M	-13.13M	17.08M	16.14M
Other Non-Cash Items	5.52M	-160.67K	-596.94K	1.18M	-5.51M	400.71M	31.62M	9.81M	902K	-61.55M
Working Capital Changes	193.65K	310.99K	-21.85M	-66.02M	2.75M	64.32M	-1.66M	-104.4M	-87.74M	-57.41M
Change in Receivables	-4K	-82.09K	-24.74M	-71.23M	-6.62M	58.08M	-4.58M	-173.41M	-89.32M	-46.15M
Change in Inventory	0	127	-486.27K	-825.77K	-1.09M	-719.11K	142.7K	540.77K	-16K	-1.56M
Change in Payables	119.22K	402.25K	1.63M	6.23M	6.27M	9.69M	-2.25M	-10.72M	37.85M	27.92M
Cash from Investing	2.05K	-116.96K	-31.23M	-61.19M	-36.98M	-4.34M	-11.24M	-2.67M	-5.24M	-6.38M
Capital Expenditures	0	0	-32.28M	-61.19M	-36.93M	-14.63M	-9.5M	-2.3M	0	-1.12M
CapEx % of Revenue	-	-	33.25%	22.33%	11.14%	6.67%	3.83%	0.48%	0.29%	-
Acquisitions	-30.8K	-116.96K	1.04M	0	-48.85K	10.3M	-1.74M	-361.32K	0	0
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	32.85K	0	0	0	0	0	0	0	-5.24M	-5.26M
Cash from Financing	711.5K	704.57K	21.71M	-7.97M	-125.85M	-48.13M	-2.27M	1.09M	-97.95M	-140.69M
Debt Issued (Net)	461K	0	35.57M	41.27M	-3.22M	-5.59M	2.65M	-7.4M	-19.44M	-19.99M
Equity Issued (Net)	275K	0	0	120K	0	4.76M	0	9.2M	-5M	-5M
Dividends Paid	0	0	-18.9M	-59.05M	-144.34M	-51.23M	-5.21M	-6.44M	0	-42.17M
Share Repurchases	0	0	0	0	0	0	0	0	-5M	-5M
Other Financing	-24.5K	756.39K	5.05M	9.69M	21.71M	3.93M	298.03K	5.73M	-73.51M	-73.52M
Net Change in Cash	-1.07K▲ 0%	109.82K▲ 10334.7%	2.6M▲ 2271.1%	17.51M▲ 572.5%	10.6M▼ 39.4%	-1.86M▼ 117.6%	-12.25M▼ 557.7%	21.58M▲ 276.1%	144.93M▲ 571.6%	122.92M▲ 0%
Free Cash Flow	-714.62K▲ 0%	-480.05K▲ 32.8%	-20.15M▼ 4097.6%	25.48M▲ 226.5%	136.51M▲ 435.7%	35.97M▼ 73.6%	-8.24M▼ 122.9%	20.85M▲ 353.0%	245.6M▲ 1077.9%	270.22M▲ 0%
FCF Margin %	-1332.08%	-525.37%	-20.76%	9.3%	41.17%	16.4%	-3.33%	4.34%	28.06%	30.71%
FCF Growth %	-160.6%	32.82%	-4097.63%	226.46%	435.67%	-73.65%	-122.91%	353.02%	1077.94%	289.18%
FCF per Share	-0.17	-0.07	-4.87	5.94	34.54	8.50	-1.87	4.09	36.35	36.35
FCF Conversion (FCF/Net Income)	-1.23x	0.17x	0.58x	0.82x	1.31x	-0.12x	-0.03x	0.44x	3.51x	2.80x
Interest Paid	0	0	427.4K	3.25M	4.1M	4.62M	1.64M	3.47M	0	11.86M
Taxes Paid	0	0	0	181.34K	335.34K	8.23M	849.36K	798.99K	0	66.8M

NUTX Key Ratios

Nutex Health, Inc. (NUTX) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025	TTM
Return on Equity (ROE)	24.57%	-645.75%	84.82%	106.93%	78.24%	-272.38%	-45.92%	37.14%	22.64%	22.21%
Return on Invested Capital (ROIC)	-155.5%	-109.45%	32.03%	52.85%	42.15%	-88.74%	-6.95%	23.56%	38%	38%
Gross Margin	-952%	31.82%	100%	57.51%	54.08%	7.03%	14.04%	40.89%	50.76%	47.47%
Net Margin	1084.99%	-3079.95%	21.56%	38.67%	39.99%	-193.7%	-18.49%	10.87%	8.09%	10.95%
Debt / Equity	0.16x	-	2.36x	1.02x	0.93x	2.22x	3.49x	1.69x	0.83x	0.83x
Interest Coverage	-15.35x	-1.31x	10.09x	23.66x	28.35x	-32.60x	-1.97x	6.51x	12.01x	9.13x
FCF Conversion	-1.23x	0.17x	0.58x	0.82x	1.31x	-0.12x	-0.03x	0.44x	3.51x	2.80x
Revenue Growth	-	70.32%	106120.79%	182.34%	20.98%	-33.85%	12.93%	93.8%	82.36%	40.95%

NUTX SEC Filings & Documents

Nutex Health, Inc. (NUTX) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

Material company update

Apr 30, 2026·SEC

Material company update

Apr 23, 2026·SEC

Material company update

Mar 5, 2026·SEC

10-K Annual Reports

FY 2026

Mar 5, 2026·SEC

FY 2025

Mar 31, 2025·SEC

FY 2024

Mar 29, 2024·SEC

10-Q Quarterly Reports

FY 2026

Apr 30, 2026·SEC

FY 2025

Nov 19, 2025·SEC

FY 2025

Nov 18, 2025·SEC

NUTX Frequently Asked Questions

Nutex Health, Inc. (NUTX) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Nutex Health, Inc. (NUTX) reported $880.0M in revenue for fiscal year 2025. This represents a 69387% increase from $1.3M in 2010.

Nutex Health, Inc. (NUTX) grew revenue by 82.4% over the past year. This is strong growth.

Yes, Nutex Health, Inc. (NUTX) is profitable, generating $96.4M in net income for fiscal year 2025 (8.1% net margin).

Dividend & Returns

Nutex Health, Inc. (NUTX) has a return on equity (ROE) of 22.6%. This is excellent, indicating efficient use of shareholder capital.

Nutex Health, Inc. (NUTX) generated $270.2M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More NUTX

Nutex Health, Inc. (NUTX) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→

Nutex Health, Inc.(NUTX)Earnings, Financials & Key Ratios

NUTX Key Insights

✓Strengths

✗Weaknesses

NUTX Price & Volume

NUTX Growth Metrics

Revenue CAGR

Profit CAGR

EPS CAGR

Return on Capital

NUTX Recent Earnings

NUTX Peer Comparison

Compare NUTX vs Peers

vs ADUS

vs HCA

Compare Top 5

NUTX Income Statement

NUTX Balance Sheet

NUTX Cash Flow Statement

NUTX Key Ratios

NUTX SEC Filings & Documents

8-K Announcements

10-K Annual Reports

10-Q Quarterly Reports

NUTX Frequently Asked Questions

Explore More NUTX

Total Return Calculator

DCA Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Valuation